ARCHIVES

Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus

This article is from The Cancer Letter archive.

Vol. 40 No. 23 | June 6, 2014

Download PDF Visit The Full Archive

Related Articles

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

Funding Opportunities: Lustgarten Foundation Request For Proposals; RFAs Available; NCI Grant Supplements.

June 20, 2003

Cancer Surveillance: risk Factors Explain SF Breast Cancer Rates

July 25, 1997

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

Prostate Cancer Prevention Trial Begins At 222 U.S. Sites

October 22, 1993

Correction: Appropriations Reports Included Language of Minorities and Underserved

October 15, 1999